(Press-News.org) TAMPA, Fla. (Oct. 30, 2025) — Two companion studies published in Cancer Research from scientists at Moffitt Cancer Center identify distinct but complementary approaches to overcoming drug resistance in KRAS G12C–mutant non-small cell lung cancer.
RAS genes produce proteins that act like on/off switches for cell growth. In healthy cells, this helps regulate normal tissue function. But when RAS is mutated, especially in cancers like non-small cell lung cancer, it can become stuck in the “on” position, driving uncontrolled tumor growth. KRAS G12C is one of the most common and aggressive mutations. According to the Lung Cancer Foundation of America, approximately 15–25% of patients with non-small cell lung cancer have a KRAS mutation, with the G12C subtype being the most common, found in about 10–14% of cases.
The first study shows that cancers can reactivate RAS signaling to evade KRAS G12C inhibitors, but next-generation RAS(ON) inhibitors can block this escape and restore tumor control. The second study demonstrates that targeting CDK12/13, key regulators of DNA repair and mitosis, can delay or prevent resistance and selectively kill resistant cancer cells. Together, these findings offer a dual-pronged strategy to extend treatment response and improve outcomes for patients.
Key Findings:
Tumors treated with KRAS G12C inhibitors often reactivate RAS signaling through multiple resistance mechanisms.
RAS(ON) inhibitors including RMC-7977 can block both mutant and wildtype RAS, shutting down these escape routes.
Resistance is also accompanied by increased sensitivity to CDK12/13 inhibitors, which disrupt DNA repair and induce mitotic arrest.KRAS and CDK12/13 inhibitor co-treatment delayed resistance and could overcome RAS-independent, EMT-driven resistance mechanism
These studies offer a preclinical roadmap for new clinical trials aimed at extending the durability of KRAS-targeted therapy.
Why is resistance to KRAS G12C inhibitors such a critical challenge?
These therapies have been game changers, but their benefits often don’t last. Tumors find ways to reactivate growth pathways or adapt through non-genetic mechanisms, making resistance common.
How do RAS(ON) inhibitors help address this?
RAS(ON) inhibitors target the active state of RAS, which allows researchers to shut down not just the original driver mutation but also the wildtype RAS that tumors often turn to as a workaround. This helps close off escape routes.
Where does CDK12/13 inhibition fit in?
Resistance also makes tumors vulnerable in another way. They become more dependent on DNA repair and mitotic control. CDK12/13 inhibitors exploit this weakness, inducing mitotic arrest and tumor cell death in resistant models
What happens when you combine these approaches?
Combining KRAS G12C inhibitors with CDK12/13 blockade delayed or prevented the emergence of resistance in both cell culture and animal models, extending the duration of treatment response.
How could these findings impact patients?
These two studies provide a clearer map for translation into the clinic. By focusing on understanding the precise mechanisms of resistance, combinations of agents can be appropriately delivered to overcome the resistant state.
These studies were supported by the National Cancer Institute (5R01CA262530-0, P30-CA076292) and State of Florida Bankhead Coley Grant (5BC07).
About Moffitt Cancer Center
Moffitt is dedicated to one lifesaving mission: to contribute to the prevention and cure of cancer. The Tampa-based facility is one of only 58 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s scientific excellence, multidisciplinary research, and robust training and education. Moffitt’s expert nursing staff is recognized by the American Nurses Credentialing Center with Magnet® status, its highest distinction. For more information, call 1-888-MOFFITT (1-888-663-3488), visit MOFFITT.org, and follow the momentum on Facebook, X, Instagram and YouTube.
###
END
A safer America will require bold investment in discovering, implementing, and scaling solutions that reduce firearm harms—especially those that center the people and communities most affected. That was the clear message from the JAMA Summit on Firearm Violence, which convened 60 leaders from across the nation to chart a roadmap toward reducing firearm violence, injuries, and deaths in the United States to record lows by 2040. The full report findings of the 2025 Summit are published in JAMA this month.
Over two days, experts from public health, medicine, law, economics, and industry participated in sessions focused on:
Achieving the safest ...
Global environmental DNA (eDNA) surveys significantly expand known geographic and ecological niche ranges of marine fish, highlighting current biases in conservation and ecological modeling
In your coverage, please use this URL to provide access to the freely available paper in PLOS Biology: https://plos.io/42mNz7A
Article title: eDNA surveys substantially expand known geographic and ecological niche boundaries of marine fishes
Author countries: France, Switzerland, Tanzania, Indonesia
Funding: see manuscript END ...
A new study has identified over 240 scientific publications on animal models of hemorrhagic stroke that contain potentially problematic images, thereby raising concerns about the trustworthiness of the body of literature this field. The findings come from a team led by René Aquarius and Kim Wever at Radboud university medical center in the Netherlands, and are published October 30th in the open-access journal PLOS Biology.
Researchers often use images in their publications to provide evidence of whether a treatment works, for example, by showing the ...
Cheng Lyu is the winner of the 2025 Eppendorf & Science Prize for Neurobiology for her work in understanding how neural circuits assemble with such remarkable precision during development. Neural circuit assembly is a daunting challenge: young neurons must form specific connections with their correct synaptic partner among billions of others. How does the developing brain achieve such exquisite precision? What happens when it fails? To explore this unknown, Cheng Lyu and her research team turned to the fruit fly Drosophila, ...
A massive March 2025 earthquake in Myanmar tore through nearly 500 kilometers of the Sagaing Fault at extremely high speeds. In a new study – part of a package of four research articles on seismic activity in Myanmar – researchers show that an unusually thick, low-velocity fault zone acted like a high-speed corridor, driving one of the fastest and longest continental ruptures ever recorded. The largest earthquakes that occur within continental crusts can rupture faults extending for hundreds of kilometers and pose significant seismic threats. Many of these powerful events evolve into supershear ruptures – earthquakes in which the rupture front ...
Newly decoded brain circuits make memories more stable as part of learning, according to a new study led by NYU Langone Health researchers.
Published online in Science on Oct. 30, the study shows that activity in signaling pathways connecting two brain regions, the entorhinal cortex and the CA3 region of the hippocampus, help mice encode in brain circuitry maps of places.
The entorhinal/hippocampal circuit is known from past studies to be crucial for both memory formation, and the recalling of memories by completing patterns from partial cues. Reliable recall requires that hippocampal place maps remain stable, withstanding to some degree changes in the environment.
Problems ...
Chronic traumatic encephalopathy (CTE) – most often found in athletes playing contact sports – is known to share similarities with Alzheimer’s disease (AD), namely the buildup of a protein called tau in the brain. New research published today in Science finds even more commonalities between the two at the genetic level, showing CTE (like AD) is linked to damage to the genome and not just caused by repeated head impact (RHI).
The research team, a collaboration between Boston Children’s Hospital, Mass General Brigham, and Boston University, used single-cell genomic sequencing to identify somatic genetic mutations (changes in DNA that ...
Chimpanzees may have more in common with human thinkers than previously thought. A new study published in Science by researchers provides evidence that chimpanzees can rationally revise their beliefs when presented with new information.
The study, titled “Chimpanzees rationally revise their beliefs,” was conducted by a large research team that included UC Berkeley Psychology Postdoctoral Researcher Emily Sanford, UC Berkeley Psychology Professor Jan Engelmann and Utrecht University Psychology Professor Hanna Schleihauf. Their findings showed that chimpanzees — like humans ...
PITTSBURGH, Oct. 30, 2025 – An international team led by a University of Pittsburgh School of Medicine scientist has created a first-of-its-kind resource to identify those with a genetic risk for elevated ‘bad’ cholesterol -- a major contributor to heart disease.
Published today in Science, this resource can assist clinicians in predicting patient risk for heart attacks and strokes, allowing time for prevention and early treatment.
Heart disease remains the leading cause of death in the United States, claiming nearly 700,000 ...
A UCLA-led team of scientists has uncovered how the devastating magnitude 7.7 earthquake that struck Myanmar in March 2025 produced one of the longest and fastest-moving ruptures ever recorded on land.
The study, published in Science, shows that the earthquake ruptured about 530 kilometers of the Sagaing Fault, with a 450-kilometer segment racing faster than the speed of seismic shear waves—a rare phenomenon known as a supershear rupture. These “Mach-like” ruptures generate shock waves that can greatly amplify ground shaking and damage.
“Supershear earthquakes are like breaking the sound barrier, but in rock,” said Lingsen Meng, a professor of ...
